Epilepsy 2020 welcomes attendees, participants, students, speakers, organizing committee members, delegates from all over the world. We welcome you and appreciate your participation at the 6th International Conference on Epilepsy & Treatment, which is going to be held during September 21, 22, 2020 is a Webinar event and it will be organized around the theme " Impact of COVID-19 on management of Epilepsy" which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.
Epilepsy is a chronic disorder usually occurred in children and people aged above 60 years. A neurological disorder marked by sudden recurrent episodes of seizures with loss of consciousness. It is associated with abnormal electrical activity in the brain with the loss of consciousness; it may be of different types and with different episodes of seizures from person to person. Epilepsy is a non-communicable disease with approximately 50 million people in the world suffers from this disease. People with Epilepsy respond to treatment approximately within 70% of the time. About three-fourths of people with Epilepsy living in low- and middle- income countries do not get the treatment properly as they need. In many parts of the world, people with Epilepsy and their families suffer from stigma and discrimination. It is estimated that every year nearly 2.4 million people are diagnosed with Epilepsy and there are 4 to 5 in a group of 1000 people with active Epilepsy. Nearly 80% of the individuals with Epilepsy are found in developing regions.
Brain Disorders 2020 Invites and welcomes delegates, presenters, sponsors, and exhibitors from all over the globe. We are delighted to invite you all to participate and register for the 9th International Conference on Brain Disorders and Therapeutics.
Brain Disorders 2020 operating committee is gearing up for an exciting and explanatory conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world.
A Nervous system is a group of cells and nerves that carry information to and from the brain and spinal cord to various parts of the body. when these nerves are damaged due to external injuries or any other abnormalities which leads to the improper functioning of the brain and spinal cord and effect the entire functioning of the body. Inorder to treat these disorders many neurosurgical procedures are carried by neurologists using the advanced instrumentation and technologies.
Neurosurgeons perform the diagnosis and treatment of diseases of the brain, spine, and other components of the nervous system. The most common surgeries performed by neurosurgeons are brain surgery, tumor removal, clot removal, spine surgery, discectomy etc. These surgeries are performed using advanced technologies like imaging, ICG-VAG, Endoscopy etc. inorder to make the surgical procedure more effective.
ConferenceSeriesllc Ltd invites all the participants from all over the world to attend Cognitive Neuroscience on February 24-25, 2020 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Neurocognitive disorders includes Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 46 million people are living with dementia this number is expected to double by 2030 and more than triple by 2050 to 116 million. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is expected to double by 2030 and more than triple by 2050 to 116 million. No treatments available to slow or stop the brain damage caused by Alzheimer’s disease, several medications can temporarily help improve the symptoms of dementia for some people. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.